Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

This watchlist of undervalued dividend stocks focuses on companies offering solid income potential at an attractive price. Each stock on this list is chosen for its strong dividend history and the potential for steady, long-term growth in dividend payouts, making it one of the best stocks for dividend growth.

Overview

Ratings

Intrinsic Value

Valuation

Growth

Profitability

Health

Capital allocation

Momentum

Earnings

Dividends

Company name	Market Cap	Quality rating	Intrinsic value	1Y Return	Revenue	Free Cash Flow	Revenue growth	FCF margin	Gross margin	ROIC	Total Debt to Equity
Microsoft CorporationMSFT MSFT	$2,933.9B	7.0	$438.3 12.8% undervalued	(5.8%)	$261.8B	$70.0B	15.0%	26.7%	69.4%	27.5%	20.6%
Oracle CorporationORCL ORCL	$459.7B	6.4	$192.6 18.9% undervalued	43.6%	$54.9B	$9,542.0M	6.4%	17.4%	69.9%	15.5%	622.5%
Johnson & JohnsonJNJ JNJ	$401.3B	5.8	$197.3 18.0% undervalued	7.2%	$88.8B	$18.1B	4.3%	20.3%	69.1%	11.6%	51.2%
AbbVie Inc.ABBV ABBV	$372.5B	6.0	$336.1 58.9% undervalued	23.8%	$56.3B	$17.8B	3.7%	31.7%	73.6%	8.3%	1,996.0%
Cisco Systems, Inc.CSCO CSCO	$256.2B	6.1	$77.3 21.8% undervalued	33.3%	$54.2B	$13.2B	(5.3%)	24.4%	64.8%	13.0%	68.2%
Philip Morris International Inc.PM PM	$244.8B	7.1	$170.7 7.5% undervalued	84.6%	$37.8B	$10.8B	7.5%	28.5%	64.2%	21.7%	(463.0%)
Abbott LaboratoriesABT ABT	$242.4B	7.0	$174.5 24.5% undervalued	19.2%	$42.0B	$6,351.0M	4.6%	15.1%	55.6%	25.3%	31.4%
Merck & Co., Inc.MRK MRK	$234.1B	7.2	$117.1 25.7% undervalued	(22.9%)	$48.6B	$15.6B	(19.2%)	32.1%	75.5%	36.5%	0.0%
Novartis AGNVS NVS	$220.0B	6.7	$136.4 23.3% undervalued	12.0%	$51.1B	$13.8B	0.1%	27.0%	74.7%	17.7%	70.8%
Thermo Fisher Scientific Inc.TMO TMO	$201.0B	6.5	$602.4 15.0% undervalued	(9.7%)	$42.9B	$7,267.0M	0.1%	16.9%	41.5%	8.3%	63.1%
QUALCOMM IncorporatedQCOM QCOM	$176.3B	7.6	$282.7 84.0% undervalued	(6.4%)	$40.7B	$12.7B	12.1%	31.3%	56.0%	42.4%	54.2%
Intuit Inc.INTU INTU	$172.0B	6.8	$603.6 0.4% undervalued	(9.5%)	$17.2B	$5,632.0M	13.7%	32.8%	78.9%	13.3%	39.3%
Amgen Inc.AMGN AMGN	$167.9B	6.0	$462.2 48.7% undervalued	13.7%	$33.3B	$10.4B	18.2%	31.2%	61.4%	10.0%	1,022.6%
Unilever PLCUL UL	$143.6B	7.0	$90.7 57.2% undervalued	20.3%	€120.4B	€15.8B	7.0%	13.1%	71.4%	31.3%	142.1%
SanofiSNY SNY	$141.6B	4.8	$86.5 53.0% undervalued	23.5%	€44.3B	(€504.0M)	(22.5%)	(1.1%)	70.2%	7.4%	23.0%
TotalEnergies SETTE TTE	$139.2B	5.4	$68.8 15.1% undervalued	(2.8%)	$203.3B	$18.2B	(10.9%)	9.0%	16.3%	9.6%	50.2%
Applied Materials, Inc.AMAT AMAT	$127.9B	7.1	$235.1 54.5% undervalued	(26.9%)	$27.6B	$5,935.0M	4.3%	21.5%	47.7%	36.4%	33.6%
Medtronic plcMDT MDT	$120.9B	6.2	$114.6 21.5% undervalued	14.7%	$33.2B	$5,467.0M	2.7%	16.5%	52.7%	7.4%	53.6%
Bristol-Myers Squibb CompanyBMY BMY	$120.8B	5.8	$111.4 86.1% undervalued	23.4%	$48.3B	$13.9B	7.3%	28.9%	66.7%	11.6%	312.4%
ConocoPhillipsCOP COP	$114.6B	5.8	$108.4 17.0% undervalued	(15.3%)	$55.3B	$8,006.0M	(1.4%)	14.5%	30.5%	11.2%	37.5%

For those seeking the best stocks that pay dividends, these choices provide a compelling mix of financial stability, growth prospects, and income. These undervalued dividend stocks are positioned to deliver both steady returns and dividend appreciation, making them ideal stocks for dividend-focused portfolios.